Home | Welcome to Contract Pharma   
Last Updated Tuesday, October 21 2014
Print

Rentschler Appoints CBO



Published March 7, 2013
Frank Ternes has been appointed chief business officer, responsible for leading the planning, development and execution of all business development, sales, marketing and project management activities at Rentschler Biotechnologie.
 
Mr. Ternes has more than 25 years of experience from operations and technology positions at Boehringer Ingelheim, where he last served as senior vice president of Biopharmaceutical Contract Manufacturing.
 
"Mr. Ternes is an excellent addition to Rentschler's management board," says Dr. Nikolaus F. Rentschler, chief executive officer and owner of Rentschler. "With his broad experience in the contract manufacturing business, he has a keen understanding of technology, a strong customer focus, and a proven track record for achieving success.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On